SEC 13F Intelligence

Capital International Investors / ELV

Capital International Investors’s Elevance Health Inc Formerly Position

Does Capital International Investors own Elevance Health Inc Formerly (ELV)? Yes1.05M shares worth $308M (+0.07% of its 13F portfolio) as of Q1 2026, down from 1.59M shares the prior filed quarter.

Position Value
$308M
Q1 2026
Shares
1.05M
% of Portfolio
+0.07%
Quarters Held
29
currently held

Position History ELV

Reported value by quarter
Q1 ’19: $424MQ1 ’19Q2 ’19: $1.1BQ3 ’19: $1.4BQ4 ’19: $2.1BQ1 ’20: $1.8BQ1 ’20Q2 ’20: $2.0BQ3 ’20: $1.3BQ4 ’20: $1.3BQ1 ’21: $1.6BQ1 ’21Q2 ’21: $1.8BQ3 ’21: $1.9BQ4 ’21: $2.6BQ1 ’22: $3.1BQ1 ’22Q2 ’22: $3.1BQ3 ’22: $3.0BQ4 ’22: $2.8BQ1 ’23: $2.2BQ1 ’23Q2 ’23: $2.1BQ3 ’23: $1.4BQ4 ’23: $1.6BQ1 ’24: $1.8BQ1 ’24Q2 ’24: $2.0BQ3 ’24: $2.0BQ4 ’24: $1.4BQ1 ’25: $2.4BQ1 ’25Q2 ’25: $2.5BQ3 ’25: $955MQ4 ’25: $556MQ1 ’26: $308MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.05M$308M+0.07%
Q4 20251.59M$556M+0.09%
Q3 20252.95M$955M+0.15%
Q2 20256.49M$2.5B+0.43%
Q1 20255.56M$2.4B+0.48%
Q4 20243.88M$1.4B+0.27%
Q3 20243.85M$2.0B+0.38%
Q2 20243.73M$2.0B+0.42%
Q1 20243.50M$1.8B+0.37%
Q4 20233.37M$1.6B+0.36%
Q3 20233.13M$1.4B+0.35%
Q2 20234.69M$2.1B+0.50%
Q1 20234.85M$2.2B+0.57%
Q4 20225.48M$2.8B+0.75%
Q3 20226.67M$3.0B+0.88%
Q2 20226.42M$3.1B+0.84%
Q1 20226.27M$3.1B+0.70%
Q4 20215.64M$2.6B+0.55%
Q3 20215.20M$1.9B+0.44%
Q2 20214.62M$1.8B+0.40%
Q1 20214.36M$1.6B+0.40%
Q4 20204.18M$1.3B+0.37%
Q3 20204.77M$1.3B+0.40%
Q2 20207.52M$2.0B+0.65%
Q1 20208.12M$1.8B+0.75%
Q4 20196.98M$2.1B+0.72%
Q3 20195.68M$1.4B+0.52%
Q2 20193.75M$1.1B+0.42%
Q1 20191.48M$424M+0.18%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Capital International Investors’s full portfolio or all institutional holders of ELV.